Business
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025 Vancouver, June 20, 20...
About this update from Leading Edge Materials Corp.
[{"type":"text","content":"LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025\n\n\n\n\n LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025\n \n\n\n\n Vancouver, June 20, 2025 – Leading Edge Materials Corp.\n \n (“\n \n Leading Edge Materials\n \n ” or the “\n \n Company\n \n ”) (\n \n TSXV: LEM\n \n ) (\n \n Nasdaq First North: LEMSE\n \n ) (\n \n OTCQB: LEMIF\n \n )\n \n (FRA: 7FL)\n \n announces results for the fiscal period ending April 30, 2025. All references to dollar amounts in this release are in Canadian dollars.\n \n\n\n Highlights During and After the Quarter\n \n\n\n During the three months ended April 30, 2025:\n \n\n •        On February 9, 2025, the Company provided an update on a Rapid Development Plan (“RDP”) for Norra Kärr, to be in production in the shortest possible timeframe, supplying HREE-rich eudialyte concentrate and industrial mineral nepheline syenite.\n \n\n •        The Company provided an update on the value creation options being considered for Woxna Graphite, on February 16, 2025, including a possible restart of operations, the production of high-quality flake graphite concentrate.\n \n\n •        On March 23, 2025, the Company provided a progress update on Norra Kärr, in the context of the European Commission’s (“EC”) Joint White Paper for European Readiness 2030, highlighting the increasing geopolitical competition over critical raw materials (“CRMs”) and the need for the EU and its member states to build strategic reserves of raw materials.\n \n\n •        On March 25, 2025, the EU announced its first list of Strategic Projects under the Critical Raw Materials Act (“CRMA”); Norra Kärr was not included. The Company stated its plan to reapply in the next round of applications.\n \n\n •        On April 23, 2025, the Company announced granting of stock options (the “Options”) to directors, officers and consultants of the Company to purchase an aggregate of 6,850,000 common shares (the “Optioned Shares”) of the Company, at ex...